Suitability of myskin™

Indications
Myskin™ is indicated for use on diabetic foot ulcers in standard care for the treatment of neuropathic full-thickness ulcers of at least four weeks duration, which have not responded to conventional treatment.

Myskin™ is indicated for the treatment of burns in place of or in addition to skin grafting. Myskin can be applied over meshed skin grafts. Where skin grafts are taken in the treatment of burns or reconstructive surgery, myskin™ can be used for re-epithelialisation of graft donor sites.

Use of myskin™ in venous leg ulcers in combination with standard therapeutic compression bandaging is being evaluated for the treatment of non-infected partial and full-thickness skin ulcers due to venous insufficiency. Myskin™ may also be effective on other non-healing wounds such as pre-tibial lascerations and pressure ulcers.

Contraindications
Myskin™ is contraindicated for use on:

Patients with ischaemic toes or both foot pulses (dorsalis pedis, posterior tibial) impalpable on the affected foot
Patients who are, or might become, pregnant during the course of the treatment
Acute Charcot neuropathic osteoarthropathy
Patients who have skin conditions which may affect healing (e.g. psoriasis) or are on treatments which may impair wound healing (such as systemic steroids or immunosuppressants)
Clinically significant active infection (involving soft tissue or bone), usually characterised as ‘critically colonised’.
Significant peripheral oedema

Click here to view the myskin™ clinician information document (Acrobat Reader required)